ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Gross Profit Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-15.43%
↓ 2466% below average
Average (30q)
0.65%
Historical baseline
Range
High:399.34%
Low:-867.01%
Volatility
194163.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -15.43% |
| Q2 2025 | -14.16% |
| Q1 2025 | 34.96% |
| Q4 2024 | -11.78% |
| Q3 2024 | 8.77% |
| Q2 2024 | 4.18% |
| Q1 2024 | 114.34% |
| Q4 2023 | -867.01% |
| Q3 2023 | -22.17% |
| Q2 2023 | -4.56% |
| Q1 2023 | -72.56% |
| Q4 2022 | -7.62% |
| Q3 2022 | 399.34% |
| Q2 2022 | -67.31% |
| Q1 2022 | 183.06% |
| Q4 2021 | 28.43% |
| Q3 2021 | 247.49% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | -54.26% |
| Q2 2019 | 10.48% |
| Q1 2019 | 23.29% |
| Q4 2018 | 0.00% |
| Q3 2018 | 2.73% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |